Replies to post #193056 on Biotech Values

[ronpopeil]

Still love the potential but pricing is very disappointing

[DewDiligence]

PIRS’ pro forma 6/30/15 cash balance—including net proceeds of the Jul 2015 public offering—was $38.3M:

http://finance.yahoo.com/news/pieris-pharmaceuticals-reports-financial-results-215112808.html

[DewDiligence]

PIRS moving corporate HQ from Germany to Boston:

http://finance.yahoo.com/news/pieris-pharmaceuticals-strenghtens-senior-management-123000689.html

Everybody in biotech wants to be in Boston these days.

[DewDiligence]

PIRS presents preclinical data on CD137/HER2 bispecific mAbs:

http://finance.yahoo.com/news/pieris-pharmaceuticals-presents-positive-preclinical-114307224.html